Sparc Life

Mumbai, India Founded: 2006 • Age: 20 yrs
Therapies for cancer and inflammatory diseases are developed.
Annual revenue $8.4M Latest available
Total funding - 1 rounds
Employees 512 Tracked headcount
Investors - Known backers
Products 4 Services tracked
Competitors 10 Brand Intelligence

About Sparc Life

Sparc Life is a company based in Mumbai (India) founded in 2006. The company has 512 employees as of March 31, 2024. Sparc Life offers products and services including Vodobatinib, Vibozilimod, SBO-154, and SCD-153. Sparc Life operates in a competitive market with competitors including Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.

  • Headquarter Mumbai, India
  • Employees 512 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Sun Pharma Advanced Research Co. Ltd.
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $8.4 M (USD)
    -5
    as on Mar 31, 2025
  • Net Profit
    -$40.15 M (USD)
    11.55
    as on Mar 31, 2025
  • EBITDA
    -$37.69 M (USD)
    19.38
    as on Mar 31, 2025
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    512

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Sparc Life

Sparc Life is a publicly listed company on the NSE with ticker symbol SPARC in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: SPARC · Sector: Health technology · India

Products & Services of Sparc Life

Sparc Life offers a comprehensive portfolio of products and services, including Vodobatinib, Vibozilimod, SBO-154, and SCD-153.

Product name locked
Category locked
Primary

BCR-ABL inhibitor for treating refractory CML in oncology.

Product name locked
Category locked
Locked

Selective S1PR1 agonist for psoriasis and atopic dermatitis.

Product name locked
Category locked
Locked

Anti-MUC-1 ADC targeting multiple tumors in oncology.

Product name locked
Category locked
Locked

Undisclosed compound for treating alopecia areata.

People of Sparc Life

Headcount 200-500
Employee Profiles 23
Employee Profiles
People
Vikas Nema
Senior Manager
People
Rajashree Kadam
Manager-2-formulation Development
People
Venkata Palle
Executive Vice President And Global Head Of Drug Discovery And Preclinical Development
People
Anil Raghavan
Chief Executive Officer

Unlock access to complete

Funding Insights of Sparc Life

Investments & Acquisitions by Sparc Life

Investments
Premium access

Investment portfolio details for Sparc Life

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Sparc Life

Premium access

Detailed financials for Sparc Life

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Sparc Life Comparisons

Sparc Life Primary company
Description
Therapies for cancer and inflammatory diseases are developed...
Location
Mumbai, India
Founded Year
2006
Annual Revenue
$8.4 M (USD)
Net Profit
-$40.15 M (USD)
EBITDA
-$37.69 M (USD)
Employees
512
As of 2024
Premium access

Peer comparison for Sparc Life

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Sparc Life

Sparc Life operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical products are manufactured and marketed worldwide.
Locked Locked Locked
Biopharmaceutical research and drug development are conducted globally by AbbVie.
Locked Locked Locked
Traditional pharmaceutical medicines are developed for multiple health fields.
Locked Locked Locked
Pharmaceuticals and diagnostics kits are developed for various diseases.
Locked Locked Locked
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured.
Locked Locked Locked
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
Premium access

Detailed competitors of Sparc Life

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Sparc Life

Premium access

Complete news archive for Sparc Life

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sparc Life

Sparc Life was founded in 2006 and raised its 1st funding round 15 years after it was founded.

Sparc Life is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Anil Raghavan is the current CEO of Sparc Life.

As of Mar 31, 2024, the latest employee count at Sparc Life is 512.

Annual revenue of Sparc Life is $8.4M as on Mar 31, 2025.

Sun Pharma Advanced Research Company is developing therapies for cancer and inflammatory diseases. The company was formed as a spin-out from Sun Pharma for all their innovative drug discovery. Their first lead candidate, Sun K706, is a tyrosine kinase inhibitor, intended for the treatment of chronic myelogenous leukemia on the most resistant form of mutation in leukemic cells - T315I mutation. The second candidate is Sun 0597, a novel, safe non-systemic glucocorticoid to treat inflammations of the airway, skin, eye, and gastrointestinal tract. All other candidates are in preclinical stages.

Sparc Life's top competitors include Merck, Roivant Sciences and Amgen.

Sparc Life offers Vodobatinib, Vibozilimod, SBO-154, and SCD-153.

Yes, Sparc Life is publicly traded on NSE under the ticker symbol SPARC.

The ticker symbol of Sparc Life is SPARC on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available